Evidence map›Paper›PMID 38853162›Full record

ArticleScientific reports2024

Motor assessment of X-linked dystonia parkinsonism via machine-learning-based analysis of wearable sensor data.

Federico Parisi, Giulia Corniani, Paolo Bonato, David Balkwill, Patrick Acuna, Criscely Go, Nutan Sharma, Christopher D Stephen

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Federico ParisiDepartment of Physical Medicine and Rehabilitation, Motion Analysis Laboratory, Spaulding Rehabilitation Hospital and Harvard Medical School, Charlestown, MA, 300 1st Avenue 02129, USA.
Giulia CornianiDepartment of Physical Medicine and Rehabilitation, Motion Analysis Laboratory, Spaulding Rehabilitation Hospital and Harvard Medical School, Charlestown, MA, 300 1st Avenue 02129, USA.
Paolo BonatoDepartment of Physical Medicine and Rehabilitation, Motion Analysis Laboratory, Spaulding Rehabilitation Hospital and Harvard Medical School, Charlestown, MA, 300 1st Avenue 02129, USA. pbonato@mgh.harvard.edu.
David BalkwillJenks Vestibular Physiology Laboratory, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
Patrick AcunaDepartment of Neurology, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, Suite 2000, Boston, MA, 02114, USA.
Criscely GoDepartment of Behavioral Medicine, Jose Reyes Memorial Medical Center, Manila, Philippines.
Nutan SharmaDepartment of Neurology, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, Suite 2000, Boston, MA, 02114, USA.
Christopher D StephenDepartment of Neurology, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, Suite 2000, Boston, MA, 02114, USA. cstephen@mgh.harvard.edu.

Funding

TorsinA as a key link in receptor-mediated signalingP01NS087997 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BREAKEFIELD, XANDRA OWENS · 2015 to 2019
$6.4M
Clinical Trial Readiness In X-Linked Dystonia Parkinsonism: Assessment of Sensor-Based And Blood Biomarkers for Early Detection and Monitoring Disease ProgressionK23NS118045 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI STEPHEN, CHRISTOPHER D · 2021 to 2025
$1.1M
NIH HHS 1K23NS118045-01A1NIH HHS P01NS087997NINDS NIH HHS K23 NS118045
6 · The paper itself

Abstract

X-linked dystonia parkinsonism (XDP) is a neurogenetic combined movement disorder involving both parkinsonism and dystonia. Complex, overlapping phenotypes result in difficulties in clinical rating scale assessment. We performed wearable sensor-based analyses in XDP participants to quantitatively characterize disease phenomenology as a potential clinical trial endpoint. Wearable sensor data was collected from 10 symptomatic XDP patients and 3 healthy controls during a standardized examination. Disease severity was assessed with the Unified Parkinson's Disease Rating Scale Part 3 (MDS-UPDRS) and Burke-Fahn-Marsden dystonia scale (BFM). We collected sensor data during the performance of specific MDS-UPDRS/BFM upper- and lower-limb motor tasks, and derived data features suitable to estimate clinical scores using machine learning (ML). XDP patients were at varying stages of disease and clinical severity. ML-based algorithms estimated MDS-UPDRS scores (parkinsonism) and dystonia-specific data features with a high degree of accuracy. Gait spatio-temporal parameters had high discriminatory power in differentiating XDP patients with different MDS-UPDRS scores from controls, XDP freezing of gait, and dystonic/non-dystonic gait. These analyses suggest the feasibility of using wearable sensor data for deriving reliable clinical score estimates associated with both parkinsonian and dystonic features in a complex, combined movement disorder and the utility of motion sensors in quantifying clinical examination.

Indexed as

Dystonic DisordersGenetic Diseases, X-LinkedMachine LearningWearable Electronic DevicesAdultFemaleGaitHumansMaleMiddle AgedParkinsonian DisordersSeverity of Illness IndexDigital healthDystoniaDystonia parkinsonismMachine LearningParkinsonismWearable sensors

Identifiers

PMID38853162
PMCPMC11162996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.